Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-24-000018
Filing Date
2024-01-04
Accepted
2024-01-04 16:04:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2938
  Complete submission text file 0001973141-24-000018.txt   4303
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Subject) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39264 | Film No.: 24511771
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address
Regnante Keith (Reporting) CIK: 0001682068 (see all company filings)

Type: 144